Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 201

1.

Preferences for Pre-exposure Prophylaxis Service Delivery Among Female Sex Workers in Malawi: A Discrete Choice Experiment.

Lancaster KE, Lungu T, Bula A, Shea JM, Shoben A, Hosseinipour MC, Kohler RE, Hoffman IF, Go VF, Golin CE, Wheeler SB, Miller WC.

AIDS Behav. 2019 Nov 13. doi: 10.1007/s10461-019-02705-3. [Epub ahead of print]

PMID:
31720955
2.

How faithfully do HIV clinicians administer the PHQ-9 depression screening tool in high-volume, low-resource clinics? Results from a depression treatment integration project in Malawi.

Pence BW, Stockton MA, Mphonda SM, Udedi M, Kulisewa K, Gaynes BN, Hosseinipour MC.

Glob Ment Health (Camb). 2019 Oct 2;6:e21. doi: 10.1017/gmh.2019.22. eCollection 2019.

3.

Distal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1-Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings.

Vecchio AC, Marra CM, Schouten J, Jiang H, Kumwenda J, Supparatpinyo K, Hakim J, Sacktor N, Campbell TB, Tripathy S, Kumarasamy N, La Rosa A, Santos B, Silva MT, Kanyama C, Firnhaber C, Hosseinipour MC, Mngqibisa R, Hall C, Cinque P, Robertson K.

Clin Infect Dis. 2019 Aug 12. pii: ciz745. doi: 10.1093/cid/ciz745. [Epub ahead of print]

PMID:
31630166
4.

"The Drug Will Help Protect My Tomorrow": Perceptions of Integrating PrEP into HIV Prevention Behaviors Among Female Sex Workers in Lilongwe, Malawi.

Shea J, Bula A, Dunda W, Hosseinipour MC, Golin CE, Hoffman IF, Miller WC, Go VF, Lungu T, Lancaster KE.

AIDS Educ Prev. 2019 Oct;31(5):421-432. doi: 10.1521/aeap.2019.31.5.421.

5.

Safety and efficacy of Option B+ ART in Malawi: few severe maternal toxicity events or infant HIV infections among pregnant women initiating tenofovir/lamivudine/efavirenz.

Harrington BJ, DiPrete BL, Jumbe AN, Ngongondo M, Limarzi L, Wallie SD, Chagomerana MB, Hosseinipour MC; S4 Study Team.

Trop Med Int Health. 2019 Oct;24(10):1221-1228. doi: 10.1111/tmi.13296. Epub 2019 Aug 19.

PMID:
31381233
6.

Bubble CPAP and oxygen for child pneumonia care in Malawi: a CPAP IMPACT time motion study.

Sessions KL, Mvalo T, Kondowe D, Makonokaya D, Hosseinipour MC, Chalira A, Lufesi N, Eckerle M, Smith AG, McCollum ED.

BMC Health Serv Res. 2019 Jul 31;19(1):533. doi: 10.1186/s12913-019-4364-y.

7.

What interventions are effective in improving uptake and retention of HIV-positive pregnant and breastfeeding women and their infants in prevention of mother to child transmission care programmes in low-income and middle-income countries? A systematic review and meta-analysis.

Puchalski Ritchie LM, van Lettow M, Pham B, Straus SE, Hosseinipour MC, Rosenberg NE, Phiri S, Landes M, Cataldo F; the PURE consortium.

BMJ Open. 2019 Jul 29;9(7):e024907. doi: 10.1136/bmjopen-2018-024907. Erratum in: BMJ Open. 2019 Aug 18;9(8):e024907corr1.

8.

The Role of Depression Screening and Treatment in Achieving the UNAIDS 90-90-90 Goals in Sub-Saharan Africa.

Kulisewa K, Stockton MA, Hosseinipour MC, Gaynes BN, Mphonda S, Udedi MM, Pence BW.

AIDS Behav. 2019 Sep;23(Suppl 2):153-161. doi: 10.1007/s10461-019-02593-7.

9.

The effectiveness of depression management for improving HIV care outcomes in Malawi: protocol for a quasi-experimental study.

Udedi M, Stockton MA, Kulisewa K, Hosseinipour MC, Gaynes BN, Mphonda SM, Pence BW.

BMC Public Health. 2019 Jun 26;19(1):827. doi: 10.1186/s12889-019-7132-3.

10.

Female adherence self-efficacy before and after couple HIV testing and counseling within Malawi's Option B+ program.

Wesevich A, Hosseinipour MC, Golin CE, McGrath N, Tsidya M, Chimndozi L, Bhushan N, Hoffman I, Miller WC, Rosenberg NE.

AIDS Care. 2019 Jun 25:1-5. doi: 10.1080/09540121.2019.1634789. [Epub ahead of print]

PMID:
31238717
11.

Ethical issues raised by cluster randomised trials conducted in low-resource settings: identifying gaps in the Ottawa Statement through an analysis of the PURE Malawi trial.

Mtande TK, Weijer C, Hosseinipour MC, Taljaard M, Matoga M, Goldstein CE, Nyambalo B, Rosenberg NE.

J Med Ethics. 2019 Jun;45(6):388-393. doi: 10.1136/medethics-2019-105374. Epub 2019 Jun 12.

12.

One year mortality outcomes from the ACTA trial of cryptococcal meningitis treatment in Malawi.

Kanyama C, Molloy SF, Chan AK, Lupiya D, Chawinga C, Adams J, Bright P, Lalloo DG, Heyderman RS, Lortholary O, Jaffar S, Loyse A, van Oosterhout JJ, Hosseinipour MC, Harrison TS.

Clin Infect Dis. 2019 Jun 1. pii: ciz454. doi: 10.1093/cid/ciz454. [Epub ahead of print]

PMID:
31155650
13.

Cabotegravir is Not Associated with Weight Gain in HIV-uninfected Individuals in HPTN 077.

Landovitz RJ, Zangeneh SZ, Chau G, Grinsztejn B, Eron JJ, Dawood H, Magnus M, Liu AY, Panchia R, Hosseinipour MC, Kofron R, Margolis DA, Rinehart A, Adeyeye A, Burns D, McCauley M, Cohen MS, Currier JS.

Clin Infect Dis. 2019 May 24. pii: ciz439. doi: 10.1093/cid/ciz439. [Epub ahead of print]

PMID:
31125395
14.

The HIV diagnostic assistant: early findings from a novel HIV testing cadre in Malawi.

Flick RJ, Simon KR, Nyirenda R, Namachapa K, Hosseinipour MC, Schooley A, Kavuta E, Theu J, Kazembe PN, Ahmed S, Kim MH.

AIDS. 2019 Jun 1;33(7):1215-1224. doi: 10.1097/QAD.0000000000002159.

15.

AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study.

Ponatshego PL, Lawrence DS, Youssouf N, Molloy SF, Alufandika M, Bango F, Boulware DR, Chawinga C, Dziwani E, Gondwe E, Hlupeni A, Hosseinipour MC, Kanyama C, Meya DB, Mosepele M, Muthoga C, Muzoora CK, Mwandumba H, Ndhlovu CE, Rajasingham R, Sayed S, Shamu S, Tsholo K, Tugume L, Williams D, Maheswaran H, Shiri T, Boyer-Chammard T, Loyse A, Chen T, Wang D, Lortholary O, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN, Niessen LW.

BMJ Open. 2019 Apr 1;9(4):e026288. doi: 10.1136/bmjopen-2018-026288.

16.

Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa.

Chen T, Mwenge L, Lakhi S, Chanda D, Mwaba P, Molloy SF, Gheorghe A, Griffiths UK, Heyderman RS, Kanyama C, Kouanfack C, Mfinanga S, Chan AK, Temfack E, Kivuyo S, Hosseinipour MC, Lortholary O, Loyse A, Jaffar S, Harrison TS, Niessen LW; ACTA Trial Team.

Clin Infect Dis. 2019 Mar 13. pii: ciy971. doi: 10.1093/cid/ciy971. [Epub ahead of print]

17.

Addition of flucytosine to fluconazole for the treatment of cryptococcal meningitis in Africa: a multi-country cost-effectiveness analysis.

Shiri T, Loyse A, Mwenge L, Chen T, Lakhi S, Chanda D, Mwaba P, Molloy SF, Heyderman R, Kanyama C, Hosseinipour MC, Kouanfack C, Temfack E, Mfinanga S, Kivuyo S, Chan AK, Jarvis JN, Lortholary O, Jaffar S, Niessen LW, Harrison TS.

Clin Infect Dis. 2019 Feb 28. pii: ciz163. doi: 10.1093/cid/ciz163. [Epub ahead of print]

18.

High rates of transmitted NNRTI resistance among persons with acute HIV infection in Malawi: implications for first-line dolutegravir scale-up.

Rutstein SE, Chen JS, Nelson JAE, Phiri S, Miller WC, Hosseinipour MC.

AIDS Res Ther. 2019 Feb 22;16(1):5. doi: 10.1186/s12981-019-0220-8.

19.

Two-year evolution of latent rheumatic heart disease in Malawi.

Sanyahumbi A, Beaton A, Guffey D, Hosseinipour MC, Karlsten M, Minard CG, Penny DJ, Sable CA, Kazembe PN.

Congenit Heart Dis. 2019 Jul;14(4):614-618. doi: 10.1111/chd.12756. Epub 2019 Jan 31.

PMID:
30706669
20.

Randomized Controlled Pilot Study of Antiretrovirals and a Behavioral Intervention for Persons With Acute HIV Infection: Opportunity for Interrupting Transmission.

Miller WC, Rutstein SE, Phiri S, Kamanga G, Nsona D, Pasquale DK, Rucinski KB, Chen JS, Golin CE, Powers KA, Dennis AM, Hosseinipour MC, Eron JJ, Chege W, Hoffman IF, Pettifor AE.

Open Forum Infect Dis. 2018 Dec 19;6(1):ofy341. doi: 10.1093/ofid/ofy341. eCollection 2019 Jan.

Supplemental Content

Loading ...
Support Center